Mefque
✅ Zapobiega malarii
✅ Effective against chloroquine-resistant malaria
✅ Convenient once-weekly dosage
✅ Well-tolerated by most individuals
✅ Nadaje się do długotrwałego stosowania
Mefque contains Mefloquine.
✓ Zweryfikowany medycznie przez Morgan Ellis — Badacz farmaceutyczny · 8 lat doświadczenia · Ostatnia weryfikacja: maj 2026
Szybka odpowiedź
Mefque zawiera mefloquine 250 mg (Cipla). It is a once-weekly chemoprophylaxis option for chloroquine-resistant malaria in sub-Saharan Africa, India, Southeast Asia (excluding the Thai-Cambodia / Thai-Myanmar borders), and the Amazon. Adult dose: 250 mg once weekly, started 2–3 weeks before travel (to identify intolerance and reach steady state), continued during travel, and continued 4 weeks after return. Take with a full meal and water. Mandatory pre-travel test dose 3 weeks before departure — if neuropsychiatric side effects occur, switch to doxycycline or atovaquone-proguanil before flying. Contraindicated in patients with current or past depression, generalised anxiety disorder, psychosis, schizophrenia, bipolar disorder, seizure disorders, or significant cardiac conduction abnormality.
🛡️ Każde zamówienie jest objęte naszą Reshipment Assurance Policy — jeśli Twoja przesyłka nie dotrze w ciągu 20 dni roboczych, wysyłamy bezpłatną wymianę kurierem EMS lub ITPS.
Dlaczego warto zamawiać z MedsBase
Mefque is sourced from a WHO-GMP certified manufacturer and shipped worldwide in discreet packaging. Every order is backed by our Reshipment Assurance Policy i wspierane przez naszą Ponad 1400 opinii klientów. Wysyłka na całym świecie bez wymaganej recepty.
About Mefque
Mefque is a 250 mg mefloquine hydrochloride tablet manufactured by Cipla under WHO-GMP certified conditions. Mefloquine was developed by the US Walter Reed Army Institute of Research in the 1970s and remains one of the three modern options (with doxycycline and atovaquone-proguanil) for prophylaxis in chloroquine-resistant areas. Its long half-life enables once-weekly dosing — convenient on long trips.
How mefloquine works
Mefloquine is a 4-quinolinemethanol antimalarial. Like chloroquine it interferes with parasite haem detoxification in the food vacuole, but is active against many chloroquine-resistant strains because it does not depend on the same parasite transport mechanism. It also has activity against blood-stage P. falciparum, P. vivax, P. ovale, and P. malariae. Mefloquine has substantial CNS penetration — desirable for parasitological efficacy, but the source of its neuropsychiatric side-effect profile.
Half-life is ~ 2–3 weeks. Once-weekly dosing reaches steady state by week 7–9; this is why most authorities recommend a 2–3 week pre-travel start.
Wskazania i dawkowanie
| Wskazanie | Dawka | Harmonogram |
|---|---|---|
| Chemoprophylaxis, adult | 250 mg once weekly | Start 2–3 weeks before entering malaria area; continue weekly during exposure; continue 4 weeks after return. |
| Paediatric chemoprophylaxis (≥ 5 kg) | 5 mg/kg once weekly (max 250 mg) | Same start / continue / stop schedule. Halved tablet for smaller children — exact mg/kg matters. |
| Acute uncomplicated chloroquine-resistant P. falciparum malaria, adult | 750 mg single dose, then 500 mg 6–12 h later (1 250 mg total) | Treatment doses cause significantly more side effects than prophylactic doses. Modern WHO preference is artemisinin combination therapy where available. |
| Standby emergency self-treatment of presumptive malaria | 750 mg + 500 mg as above | For travellers in areas without rapid medical access who develop a febrile illness compatible with malaria. Not a substitute for medical evaluation. |
Efekty uboczne
- Common (10–25 %): nausea, dizziness, vivid dreams, mild insomnia, headache.
- Less common (5–10 %): anxiety, mood change, fatigue, GI upset, mild hair loss, photosensitivity.
- Rzadkie, ale istotne: depression (sometimes severe), suicidal ideation, paranoia, hallucinations, panic attacks, dissociative symptoms — these often persist after stopping the drug.
- Rzadkie, ale poważne: seizures, encephalopathy, AV-block, bradycardia, severe cutaneous reactions (Stevens-Johnson, toxic epidermal necrolysis), agranulocytosis, severe hepatotoxicity, severe vestibular disturbance.
- Ciąża: can be used in second and third trimester for prophylaxis and treatment; first-trimester data are reassuring but limited. Use the lowest effective dose.
Interakcje lekowe
| Interakcja | Efekt | Management |
|---|---|---|
| Quinine / chloroquine / hydroxychloroquine | Additive cardiotoxicity + lowered seizure threshold | Avoid combination — use one antimalarial. |
| Anticonvulsants (carbamazepine, phenytoin, valproate) | Mefloquine can lower the seizure threshold + reduces anticonvulsant levels via CYP3A4 | Mefloquine contraindicated in seizure disorder. |
| Beta-blockers / calcium channel blockers / digoxin | Additive bradycardia / AV-block | Cardiology review; consider alternative antimalarial. |
| Halofantrine | Severe QTc prolongation, fatal arrhythmia reported | Absolute contraindication. |
| Ketoconazole / strong CYP3A4 inhibitors | Raise mefloquine level + QTc effect | Unikaj kombinacji. |
| Rifampicin / rifabutin / strong CYP3A4 inducers | Lower mefloquine level — risk of prophylaxis failure | Avoid combination; choose alternative antimalarial. |
| QT-prolonging drugs (azithromycin, ondansetron, antipsychotics, SSRIs / TCAs) | Dodatkowe wydłużenie odstępu QT | Avoid in patients with electrolyte disturbance or pre-existing long QT. |
| Live oral typhoid vaccine (Ty21a) | Mefloquine inactivates the live vaccine | Complete vaccine series at least 12 hours before mefloquine. |
Przeciwwskazania i środki ostrożności
- Bezwzględne: hypersensitivity to mefloquine or related quinoline antimalarials; current or past major depression, generalised anxiety disorder, psychosis, schizophrenia, bipolar disorder, seizure disorder; severe cardiac conduction abnormality (high-grade AV-block, severe bradycardia); concurrent halofantrine.
- Strong caution: prior depression / anxiety not currently active, recent traumatic brain injury, severe hepatic or renal impairment, vestibular disorders.
- Ciąża: compatible after the first trimester; first-trimester data limited but reassuring. Untreated falciparum malaria in pregnancy is far more dangerous.
- Karmienie piersią: compatible — secreted in breast milk in low amounts insufficient for infant prophylaxis.
Przechowywanie
Store below 30 °C in a dry place, in original packaging. Keep out of reach of children.
Najczęściej zadawane pytania
Why start Mefque 2–3 weeks before travel?
Two reasons: to detect early neuropsychiatric intolerance (so you can switch antimalarial before flying) and to allow blood levels to climb toward steady state. Some authorities recommend 3 weeks; minimum is 2 weeks.
Who should NOT take mefloquine?
Anyone with current or past depression, generalised anxiety disorder, psychosis, schizophrenia, bipolar disorder, seizure disorder, severe cardiac conduction abnormality, recent traumatic brain injury, or strong family history of severe psychiatric illness. These patients should choose doxycycline (Cendox) or atovaquone-proguanil instead.
What if I get vivid dreams?
Vivid dreams alone are common (15–20 %) and often tolerable. Severe nightmares, sleep disturbance, anxiety, or mood change are reasons to switch antimalarial — do this BEFORE flying, while you still have alternatives available.
Is mefloquine still in widespread use?
Yes for prophylaxis in pregnancy (where atovaquone-proguanil is less established and doxycycline is contraindicated) and for travellers wanting once-weekly dosing on long trips. Many travel-medicine clinics now prefer atovaquone-proguanil where cost and side-effect profile are concerns; mefloquine remains a valid choice after a careful test dose.
Can I take Mefque and drink alcohol?
Moderate alcohol is acceptable. Heavy drinking amplifies CNS effects (dizziness, anxiety, mood disturbance) and should be avoided.
Does mefloquine cause permanent brain damage?
Most side effects resolve after stopping the drug. A minority of patients describe persistent symptoms (“post-mefloquine syndrome”). The mechanism is unclear and the prevalence is debated. The 3-week pre-travel test dose exists specifically to identify patients who should not continue the drug before persistent effects develop.
Can I take Mefque in pregnancy?
Yes — mefloquine is one of the preferred antimalarial prophylactics in pregnancy after the first trimester. First-trimester data are reassuring but limited. Untreated falciparum malaria in pregnancy is far more dangerous than mefloquine.
What if I miss a weekly dose?
Take it as soon as you remember. If it is more than 3 days late, take it and resume the original day-of-the-week schedule the following week. Do not double up.
Why does the dose differ for treatment vs prophylaxis?
Prophylaxis prevents the parasite from establishing infection — modest steady-state blood levels suffice. Treatment must clear an established parasitic load — much higher peak doses are needed (1 250 mg total over 12 hours), with proportionally higher side effects.
Should I take Mefque with food?
Yes — taking with a full meal substantially reduces nausea and improves absorption. Avoid taking on an empty stomach.
Can I take mefloquine for malaria treatment if I get sick on the trip?
Self-treatment of presumptive malaria is reserved for travellers in remote areas without medical access. If you can reach medical care, do that — modern artemisinin combination therapy is safer and more effective for established infection. Mefloquine treatment doses cause significantly more side effects than prophylactic doses.
Inne tabletki na malarię
- Cendox 100 mg — Doxycycline — daily alternative for travellers with neuropsychiatric contraindication to mefloquine
- Lariago 250 mg — Chloroquine — for the few remaining chloroquine-sensitive destinations only
- HCQS 200/400 mg — Hydroxychloroquine — alternative aminoquinoline with autoimmune crossover
- Primaquine 15 mg — Radical cure for P. vivax / P. ovale relapsing malaria — G6PD test required
- Quinin 300 mg — Quinine — second-line treatment for chloroquine-resistant P. falciparum
Więcej opcji w Tabletki na malarię
Ranking według liczby ostatnich zamówień MedsBase — co wybierają inni klienci w tej kategorii.
| Moc | 250 mg |
|---|---|
| Ilość | 4 Tabletki, 8 Tabletek, 12 Tabletek, 24 Tabletek |
Pytania i odpowiedzi
Produkty powiązane
Opinie
Nie ma jeszcze opinii